help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tockman, M. S.
Right arrow Articles by Fozard, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tockman, M. S.
Right arrow Articles by Fozard, J. L.

Am. J. Respir. Crit. Care Med., Vol 151, No. 2, 02 1995, 390-398.

Rapid decline in FEV1. A new risk factor for coronary heart disease mortality

MS Tockman, JD Pearson, JL Fleg, EJ Metter, SY Kao, KG Rampal, LJ Cruise and JL Fozard
Department of Environmental Health Sciences, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland 21205.

Coronary heart disease (CHD) is the leading cause of mortality in the United States. The present cohort study was conducted to determine whether rate of FEV1 loss independently predicts CHD mortality in apparently healthy men. White male Baltimore Longitudinal Study of Aging (BLSA) participants without CHD underwent clinical evaluation at 2-yr intervals; 883 had satisfactory pulmonary and lipid studies and returned for a least one visit. Cases were BLSA subjects without CHD on entry who died a "coronary death" (death from acute myocardial infarction, sudden death, or congestive heart failure in the presence of coronary artery disease). Forced expiratory maneuvers followed American Thoracic Society guidelines. Serum cholesterol, blood pressure, cigarette smoking, and body mass index were obtained from the BLSA database. There were 79 CHD deaths and 804 survivors during an average follow-up of 17.4 yr. After adjustment for age, initial FEV1% predicted, smoking status, hypertension, and cholesterol, a time- dependent proportional hazards model showed that cardiac mortality, but not all causes of mortality, generally increased with increasing quintile of FEV1 decline for the entire cohort (relative risk [RR] 2.92- 5.13) and separately for the subset of never-smokers. Thus, excess CHD mortality follows a large decline in FEV1, independent of the initial FEV1% predicted, cigarette smoking, and other common CHD risk factors.


This article has been cited by other articles:


Home page
CirculationHome page
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation, December 18, 2007; 116(25): 2992 - 3005.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. H. Downs, C. Schindler, L.-J. S. Liu, D. Keidel, L. Bayer-Oglesby, M. H. Brutsche, M. W. Gerbase, R. Keller, N. Kunzli, P. Leuenberger, et al.
Reduced Exposure to PM10 and Attenuated Age-Related Decline in Lung Function
N. Engl. J. Med., December 6, 2007; 357(23): 2338 - 2347.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R. J Hancox, R. Poulton, J. M Greene, S. Filsell, C. R McLachlan, F. Rasmussen, D R. Taylor, M. J A Williams, A. Williamson, and M. R Sears
Systemic inflammation and lung function in young adults
Thorax, December 1, 2007; 62(12): 1064 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Respiratory DiseaseHome page
J. Tkac, S. F. P. Man, and D. D. Sin
Review: Systemic consequences of COPD
Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 47 - 59.
[Abstract] [PDF]


Home page
Occup. Environ. Med.Home page
K. Sircar, E. Hnizdo, E. Petsonk, and M. Attfield
Decline in lung function and mortality: implications for medical monitoring
Occup. Environ. Med., July 1, 2007; 64(7): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1259 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. Massaro and G. D. Massaro
Toward Therapeutic Pulmonary Alveolar Regeneration in Humans
Proceedings of the ATS, November 1, 2006; 3(8): 709 - 712.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Aronson, I. Roterman, M. Yigla, A. Kerner, O. Avizohar, R. Sella, P. Bartha, Y. Levy, and W. Markiewicz
Inverse Association between Pulmonary Function and C-Reactive Protein in Apparently Healthy Subjects
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 626 - 632.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Guenegou, B Leynaert, I Pin, G Le Moel, M Zureik, and F Neukirch
Serum carotenoids, vitamins A and E, and 8 year lung function decline in a general population.
Thorax, April 1, 2006; 61(4): 320 - 326.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S Yende, G W Waterer, E A Tolley, A B Newman, D C Bauer, D R Taaffe, R Jensen, R Crapo, S Rubin, M Nevitt, et al.
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects
Thorax, January 1, 2006; 61(1): 10 - 16.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Sunyer and C. S. Ulrik
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?
Eur. Respir. J., April 1, 2005; 25(4): 587 - 588.
[Full Text] [PDF]


Home page
Eur Respir JHome page
D. D. Sin and S. F. P. Man
Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease?
Eur. Respir. J., April 1, 2005; 25(4): 589 - 590.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. D. Sin and S. F. P. Man
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Proceedings of the ATS, April 1, 2005; 2(1): 8 - 11.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. R. Blake, J. B. Meigs, D. C. Muller, S. S. Najjar, R. Andres, and D. M. Nathan
Impaired Glucose Tolerance, but not Impaired Fasting Glucose, Is Associated With Increased Levels of Coronary Heart Disease Risk Factors: Results From the Baltimore Longitudinal Study on Aging
Diabetes, August 1, 2004; 53(8): 2095 - 2100.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
C. Iribarren, I. V Tolstykh, and M. D Eisner
Are patients with asthma at increased risk of coronary heart disease?
Int. J. Epidemiol., August 1, 2004; 33(4): 743 - 748.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Zureik, S. Kony, C. Neukirch, D. Courbon, B. Leynaert, D. Vervloet, P. Ducimetiere, and F. Neukirch
Bronchial Hyperresponsiveness to Methacholine Is Associated With Increased Common Carotid Intima-Media Thickness in Men
Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1098 - 1103.
[Abstract] [Full Text]


Home page
ThoraxHome page
D D Sin and S F P Man
Impaired lung function and serum leptin in men and women with normal body weight: a population based study
Thorax, August 1, 2003; 58(8): 695 - 698.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
The European Community Respiratory Health Survey I
The European Community Respiratory Health Survey II
Eur. Respir. J., November 1, 2002; 20(5): 1071 - 1079.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. I. Harik-Khan, J. L. Fleg, and R. A. Wise
Body Mass Index and the Risk of COPD
Chest, February 1, 2002; 121(2): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. ZUREIK, A. BENETOS, C. NEUKIRCH, D. COURBON, K. BEAN, F. THOMAS, and P. DUCIMETIERE
Reduced Pulmonary Function Is Associated with Central Arterial Stiffness in Men
Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2181 - 2185.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. D. Johnson, K. C. Beck, L. J. Olson, K. A. O'Malley, T. G. Allison, R. W. Squires, and G. T. Gau
Pulmonary Function in Patients With Reduced Left Ventricular Function : Influence of Smoking and Cardiac Surgery
Chest, December 1, 2001; 120(6): 1869 - 1876.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Pelkonen, I-L Notkola, H Tukiainen, M Tervahauta, J Tuomilehto, and A Nissinen
Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study
Thorax, September 1, 2001; 56(9): 703 - 707.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Zureik, F. Kauffmann, P.-J. Touboul, D. Courbon, and P. Ducimetiere
Association Between Peak Expiratory Flow and the Development of Carotid Atherosclerotic Plaques
Arch Intern Med, July 9, 2001; 161(13): 1669 - 1676.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Engstrom, P. Wollmer, B. Hedblad, S. Juul-Moller, S. Valind, and L. Janzon
Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function : A Study From "Men Born in 1914," Malmo, Sweden
Circulation, June 26, 2001; 103(25): 3086 - 3091.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L.-A. F. BEECKMAN, M.-L. WANG, E. L. PETSONK, and G. R. WAGNER
Rapid Declines in FEV1 and Subsequent Respiratory Symptoms, Illnesses, and Mortality in Coal Miners in the United States
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 633 - 639.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. A. GRIFFITH, D. L. SHERRILL, E. M. SIEGEL, T. A. MANOLIO, H. W. BONEKAT, and P. L. ENRIGHT
Predictors of Loss of Lung Function in the Elderly . The Cardiovascular Health Study
Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 61 - 68.
[Abstract] [Full Text]


Home page
ChestHome page
G. T. Ferguson, P. L. Enright, A. S. Buist, and M. W. Higgins
Office Spirometry for Lung Health Assessment in Adults: A Consensus Statement From the National Lung Health Education Program
Chest, April 1, 2000; 117(4): 1146 - 1161.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. D. SCANLON, J. E. CONNETT, L. A. WALLER, M. D. ALTOSE, W. C. BAILEY, A. SONIA BUIST, and D. P.T. f. t. e Lung Health Study Research&n
Smoking Cessation and Lung Function in Mild-to-Moderate Chronic Obstructive Pulmonary Disease . The Lung Health Study
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 381 - 390.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. I. HARIK-KHAN, R. A. WISE, and J. L. FOZARD
Determinants of Maximal Inspiratory Pressure . The Baltimore Longitudinal Study of Aging
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1459 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. A. WISE, P. L. ENRIGHT, J. E. CONNETT, N. R. ANTHONISEN, R. E. KANNER, P. LINDGREN, P. O'HARA, G. R. OWENS, C. S. RAND, and D. P. TASHKIN
Effect of Weight Gain on Pulmonary Function after Smoking Cessation in the Lung Health Study
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 866 - 872.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society